CNC
NVO

Canandaigua National Corp’s Novo Nordisk NVO Stock Holding History

Canandaigua National Corp’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$813K Sell
12,010
-500
-4% -$29.3K 0.14% 143
2022
Q3 		$623K Hold
12,510
– – 0.11% 153
2022
Q2 		$697K Hold
12,510
– – 0.12% 151
2022
Q1 		$695K Sell
12,510
-11,990
-49% -$615K 0.11% 166
2021
Q4 		$1.37M Hold
24,500
– – 0.2% 121
2021
Q3 		$1.18M Buy
+24,500
New +$1.18M 0.19% 128

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Canandaigua National Corp's NVO Position: Q4 2022 in Review

Canandaigua National Corp reduced its Novo Nordisk (NVO) stake by 4% in Q4 2022, selling an estimated $29.3K and leaving 12,010 shares worth $813K. The position accounts for 0.14% of the portfolio, ranked #143.

Canandaigua National Corp first reported a position in NVO in Q3 2021 and has held it in 6 quarters since. The position peaked at $1.37M in Q4 2021. 1,049 funds tracked by Wall St. Rank hold NVO as of Q4 2022.

  • Canandaigua National Corp held 12,010 shares of Novo Nordisk worth $813K as of Q4 2022.
  • Canandaigua National Corp sold 500 Novo Nordisk shares in Q4 2022, an estimated $29.3K.
  • Novo Nordisk made up 0.14% of Canandaigua National Corp's portfolio in Q4 2022, its #143 holding.
  • Canandaigua National Corp first reported a position in Novo Nordisk in Q3 2021 and has held it in 6 quarters since.
  • Canandaigua National Corp's Novo Nordisk position peaked at $1.37M in Q4 2021.
  • 1,049 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2022.

Based on Canandaigua National Corp's 13F filing for Q4 2022, filed 25 Jan 2023.